Skip to content
Luna Metabolic
Menu
Ranked #51 for women · Grade C

SkinnyRx review

The rare program that compounds tirzepatide as a dissolving tablet as well as an injection — genuinely useful if the needle is what is stopping you — sold behind a four-rung commitment ladder whose cheapest rung is the only price the site ever shows you.

Visit SkinnyRx Assume any provider we list may compensate us — we may earn a commission, at no cost to you. See our disclosure.
Semaglutide
$349/mo month-to-month (from $199/mo on a 12-month plan) — the site displays only the 12-month rate
Tirzepatide
$399/mo month-to-month, injectable or dissolving tablet (from $299/mo on a 12-month plan) — the site displays only the 12-month rate
Coverage
No state list published; the offer terms report no state restrictions
Brand-name
Compounded only

The Luna Fit scorecard

SkinnyRx scored on our six women's-health factors. See the methodology.

PCOS & hormonal suitability74/100
Clinical oversight & labs67/100
Price transparency62/100
Nationwide access82/100
Ongoing support84/100
Cancellation fairness58/100

What we like

  • A compounded tirzepatide TABLET — a dissolving sublingual route for the dual GIP/GLP-1 molecule, priced identically to the injection at every rung, which is close to unique in this ranking
  • Both molecules across three routes — injection, sublingual and daily tablet — so needle aversion never means changing provider or dropping back to the single-pathway drug
  • Lower-dose "microdose" lines for both molecules are sold as their own products with their own published ladders, rather than being quoted at the full-dose price
  • US-based providers stated as licensed and board-certified, dispensing through named 503A state-licensed pharmacies, with unlimited provider messaging and free shipping included
  • You are not charged if the provider decides you do not qualify — payment is taken after the intake, and an ineligible applicant is refunded within 24–48 hours

The caveats

  • Carries an active FDA warning letter issued in February 2026 (see the notice on this page for FDA's own record)
  • Every price the site advertises is the TWELVE-MONTH rung: its own headline reads "Starting at $299/mo" while the month-to-month tirzepatide rate is $399 and the renewal price in its code is literally 399 — semaglutide is the same shape at $199 advertised against $349 month-to-month
  • The commitment is not named beside the number anywhere in the marketing copy, and the prepay rung is also what its schema.org product markup publishes as the price — so search engines and AI assistants are given the twelve-month rate as though it were the monthly one
  • The "90-day money-back guarantee" on its marketing rail is not what its refund policy says: once a provider completes the prescription review and fulfillment begins the order is non-refundable, partially used subscription periods are not refunded, bundled subscriptions are non-refundable outright, and canceling inside a committed term can have the discount clawed back
  • No labs, bloodwork or monitoring cadence is mentioned anywhere on the site — thin oversight if thyroid, androgens or metabolic markers are part of your picture
  • No LegitScript certification, no accreditation badge and no named medical director — the credential claims are the company's own and there is nothing third-party to check them against
  • Its Wegovy®, Foundayo™, Mounjaro® and Zepbound® pages are marketing only — every one is unpurchasable in its own price data, so there is no brand-name route here at all, and no brand tirzepatide despite the shelf appearing to hold one
  • Compounded semaglutide and tirzepatide are not FDA-approved, and the sublingual tablet routes are the least-studied form of either
  • No PCOS, perimenopause or menopause program of any kind — a general weight-loss shop, and nothing in it addresses the hormonal picture

The bottom line

Best for: Readers treating insulin resistance who want the dual GIP/GLP-1 molecule without a weekly injection, and who will open the plan selector and read the month-to-month rate rather than the advertised one. The rare program that compounds tirzepatide as a dissolving tablet as well as an injection — genuinely useful if the needle is what is stopping you — sold behind a four-rung commitment ladder whose cheapest rung is the only price the site ever shows you.

Ranked #51 of 65 providers we reviewed for women — see our #1 pick, CoreAge Rx, for comparison. Cancellation fairness is where SkinnyRx scores lowest, at 58/100. If that is your sticking point, start with the SkinnyRx alternatives, scored on the same six factors.

Compare with other providers

All 64 other providers we've reviewed for women, in our overall ranking order. One of those comparisons is written out in full: the SkinnyRx–CoreAge Rx head-to-head, 22 points apart on the Luna Fit Score. Directly below SkinnyRx sits Measured at #52 with 77/100 — see our ranked shortlist of Measured alternatives if that is the band you are shopping in.

Pricing, states and verification reflect SkinnyRx's public disclosures at last review; the Luna Fit Score is our editorial judgment per the methodology. Prices change — confirm on SkinnyRx's site. Not medical advice; see our disclosure.

← Back to all providers